Revenue from operations rose 9% year-on-year to ₹3,005.83 crore in Q2 FY26 from ₹2,746.72 crore in the year-ago quarter, the company said in a regulatory…
Sun Pharma beat profit forecasts on strong India demand and plans to enter the weight-loss drug market once semaglutide patents expire in 2026.
Thursday will also be the first weekly expiry of the Sensex contracts for the November series. The market will also have to react to a…
The company reported ₹2,559.3 crore in revenue from operations for the quarter ended September 30, up 17% on a year-on-year basis from ₹2,189.7 crore in…
Several major companies announced their Q2 FY26 results showcasing a mixed earnings trend across sectors. NSE posted steady profit growth with strong margins, while IndiGo…
That the automaker had no intention of investing further in the bank was made clear in August 2023, M&M’s Managing Director and CEO Anish Shah…
US Stock Market LIVE Updates: US markets extended their losses on Tuesday, with tech stocks leading the decline after months of powering Wall Street’s rally.…
The company reported ₹2,762 crore in revenue from operations, up 19% on a year-on-year basis and 10.8% on a sequential basis. Revenue in the same quarter…
The company reported ₹9,610.3 crore in revenue from operations, up 26% on a year-on-year basis from ₹7,623.3 crore in the same quarter last year.
Zydus Lifesciences has received a clean report from the USFDA for its SEZ-II manufacturing facility in Ahmedabad, with the inspection concluding with no observations. The…